Skip to main content

CORRECTION article

Front. Pharmacol., 06 December 2024
Sec. Experimental Pharmacology and Drug Discovery

Corrigendum: FOXO1-mediated autophagy regulation by miR-223 in sepsis-induced immunosuppression

  • 1College of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital, Beijing, China
  • 2Chinese PLA Medical School, Beijing, China
  • 3Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing, China
  • 4Department of Respiratory and Critical Care Medicine, Pingjin Hospital, Characteristic Medical Center of the Chinese People’s Armed Police Force, Tianjin, China
  • 5Department of Emergency, Third Medical Center of Chinese PLA General Hospital, Beijing, China
  • 6National Center of Technology Innovation for Animal Model, National Human Diseases Animal Model Resource Center, National Health Commission of China (NHC) Key Laboratory of Comparative Medicine, Institute of Laboratory Animal Sciences, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing, China

A Corrigendum on
FOXO1-mediated autophagy regulation by miR-223 in sepsis-induced immunosuppression

by Xiang G, Li Q, Lian D, Su C, Li X, Deng S and Xie L (2024). Front. Pharmacol. 15:1469286. doi: 10.3389/fphar.2024.1469286

In the published article, there was an error in the Funding statement. “The Natural Science Foundation of Shandong Province (ZR2021MH388)” was erroneously included. The correct Funding statement appears below.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (82172109) and Beijing Tongzhou District Science and Technology Plan (KJ2023CX052).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: sepsis, miR-223, CD4+ T lymphocytes, autophagy, FOXO1, immunosuppression

Citation: Xiang G, Li Q, Lian D, Su C, Li X, Deng S and Xie L (2024) Corrigendum: FOXO1-mediated autophagy regulation by miR-223 in sepsis-induced immunosuppression. Front. Pharmacol. 15:1533534. doi: 10.3389/fphar.2024.1533534

Received: 24 November 2024; Accepted: 25 November 2024;
Published: 06 December 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Xiang, Li, Lian, Su, Li, Deng and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xin Li, bGl4aW45MjA3QDE2My5jb20=; Shoulong Deng, ZGVuZ3Nob3Vsb25nQGNuaWxhcy5vcmc=; Lixin Xie, eGllbHgzMDFAMTI2LmNvbQ==

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.